Lexicon Pharmaceuticals Inc.

LXRX | NASDAQ

Price Alert Chart Builder DCF Calculator

$2.11

+$0.07 (+3.43%)

Sep 22, 2026, 1:26 PM ET · Market open

Overview Rating Statistics Financials Earnings Analysts Ownership Profile

Pro Subscription

Upgrade now for unlimited access to all data, tools and no ads.

Upgrade now ➞

Related Stocks

Company	Yield
ADCT ADC Therapeutics S.A.	N/A
BCYC Bicycle Therapeutics plc	N/A
CMPX Compass Therapeutics	N/A
FDMT 4D Molecular Therapeutics	N/A
FULC Fulcrum Therapeutics	N/A
GOSS Gossamer Bio	N/A
NMRA Neumora Therapeutics Common Stock	N/A
OCGN Ocugen	N/A
OMER Omeros	N/A

Dividend Rankings ➞

Recent News

29 days ago / globenewswire.com
Lexicon Pharmaceuticals Earns Third $10 Million Milestone Payment from Novo Nordisk Following Achievement of Key Phase 1 Development Milestone for LX9851
2 months ago / marketbeat.com
Lexicon Pharmaceuticals Q2 Earnings Call Highlights
2 months ago / seekingalpha.com
Lexicon Pharmaceuticals, Inc. (LXRX) Q2 2026 Earnings Call Transcript
2 months ago / zacks.com
Lexicon Pharmaceuticals (LXRX) Reports Q2 Loss, Lags Revenue Estimates
2 months ago / globenewswire.com
Lexicon Pharmaceuticals Reports Second Quarter 2026 Financial Results and Provides Clinical Updates
2 months ago / globenewswire.com
Lexicon Pharmaceuticals to Report Second Quarter 2026 Financial Results on August 6, 2026
4 months ago / globenewswire.com
Lexicon Pharmaceuticals to Present at the 4th Annual H.C. Wainwright BioConnect Investor Conference